JAMES A GERAGHTY Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES A GERAGHTY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES A GERAGHTY. JAMES A GERAGHTY is Director in JUNIPER PHARMACEUTICALS INC ($JNP) and Director in rEVO Biologics, Inc. ($GTCB) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Voyager Therapeutics, Inc. ($VYGR) and Director in Fulcrum Therapeutics, Inc. ($FULC) and Director in Orchard Therapeutics plc ($ORTX).
JAMES A GERAGHTY in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES A GERAGHTY: Director
Holdings: 104,770 shares
Current Value: $163,441
Latest Transaction: Jan 06 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES A GERAGHTY in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FULC, IDRA, JNP, ORTX, PIRS, GTCB, VYGR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 4.02 | 4,851 | 19,501 | 104,770 | 99.9 K to 104.8 K (+4.85 %) |
| Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 2.25 | 8,666 | 19,499 | 99,919 | 91.3 K to 99.9 K (+9.50 %) |
| Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.79 | 10,894 | 19,500 | 91,253 | 80.4 K to 91.3 K (+13.56 %) |
| May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.97 | 14,500 | 28,565 | 14,500 | |
| Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.28 | 14,926 | 19,105 | 80,359 | 65.4 K to 80.4 K (+22.81 %) |
| Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 2.57 | 14,500 | 37,265 | 14,500 | |
| Aug 08 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 5.58 | 10,000 | 55,800 | 65,433 | 55.4 K to 65.4 K (+18.04 %) |
| Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.32 | 8,096 | 10,687 | 443,465 | 435.4 K to 443.5 K (+1.86 %) |
| Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.53 | 63,000 | 96,390 | 63,000 | |
| Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.63 | 63,000 | 102,690 | 63,000 | |
| Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.63 | 9,720 | 15,844 | 435,369 | 425.6 K to 435.4 K (+2.28 %) |
| Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.44 | 52,000 | 74,880 | 52,000 | |
| May 16 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 1.34 | 10,000 | 13,400 | 425,649 | 415.6 K to 425.6 K (+2.41 %) |
| Jun 10 2015 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 3.59 | 52,500 | 188,475 | 52,500 | |
| Apr 06 2015 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 3.52 | 3,000 | 10,560 | 415,649 | 412.6 K to 415.6 K (+0.73 %) |
Page: 1